Company / Working Capital per Share
Perspective Therapeutics, Inc. Working Capital per Share History
FY2013-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital per Share
$0.35
FY2022
5-year range
$0.06 / $0.95
FY2018-FY2022
Trend
-62.9%
vs FY2021
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Working Capital per Share has fluctuated over the past 10 years, ranging from $0.06 in FY2020 to $0.95 in FY2021.
Based on SEC 10-K filings.
0.35 in FY2022 with a 5-year CAGR of +16.2%.
Improved from $0.06 to $0.35 over the past 2 years.
Working Capital per Share over time
Growth rates
- 3-Year CAGR
- +47.5%
- 5-Year CAGR
- +16.2%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2022, working capital per share decreased 62.9% year-over-year.
- Peak working capital per share was recorded in FY2021.
- Lowest working capital per share in the period was in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 5.43 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working Capital per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2022 | $0.35 | -62.9% |
| FY2021 | $0.95 | +1529.3% |
| FY2020 | $0.06 | -46.9% |
| FY2019 | $0.11 | +67.5% |
| FY2018 | $0.07 | -60.7% |
| FY2017 | $0.17 | -44.7% |
| FY2016 | $0.30 | -17.7% |
| FY2015 | $0.37 | -29.7% |
| FY2014 | $0.52 | +342.3% |
| FY2013 | $0.12 | - |
As of FY2022 · SEC 10-K · Updated Jun 24, 2026